By Sheeba M. | April 01, 2026
CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads
The Cannabidiol (CBD) market is projected to grow substantially through 2034, according to a new analysis from ResearchAndMarkets, but regulatory uncertainty in the United States continues to cloud the industry’s long-term trajectory.
The global CBD market is expected to see compound annual growth rates in the mid-teens through the forecast period. Key drivers include:
- Increasing consumer awareness of health and wellness benefits
- Expansion of hemp-derived CBD products following the 2018 Farm Bill
- Growing acceptance of cannabis-derived compounds in mainstream retail
- Rising demand for natural health alternatives
Despite the projections, the U.S. CBD industry remains in a regulatory grey zone. The 2018 Farm Bill legalized hemp and hemp-derived CBD at the federal level, but the FDA has yet to establish clear regulatory pathways for CBD in food, beverages, and dietary supplements.
Without FDA clarity:
- Companies cannot make health claims about CBD products
- CBD-infused foods and beverages remain in regulatory limbo
- Import enforcement creates uncertainty for international suppliers
The recent change in DEA scheduling posture — with cannabis rescheduling to Schedule III under consideration — could indirectly benefit CBD by creating a more rational federal framework for cannabis-derived compounds broadly.
Investors should monitor FDA’s next moves on CBD regulation, as clarity here could unlock significant growth in the consumer products segment.